FDA Advisory Committee Recommends Emergency Authorization for Pfizer's COVID Vaccine
An advisory committee to the U.S. Food and Drug Administration (FDA) voted late on Thursday to recommend that emergency use authorization (EUA) be given to Pfizer's (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) COVID-19 vaccine BNT162b2. The FDA doesn't have to go along with the committee's recommendation but is widely expected to do so after both Canada and the U.K. authorized emergency use of the vaccine.
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) consists of independent industry vaccine experts. The members of the committee spent hours on Thursday discussing Pfizer's and BioNTech's EUA filing for BNT162b2. In particular, the committee focused on the vaccine's safety profile.
Image source: Getty Images.
Source Fool.com
